110 related articles for article (PubMed ID: 38766071)
1. Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain.
Martin L; Stratton HJ; Gomez K; Le Duy D; Loya-Lopez S; Tang C; Calderon-Rivera A; Ran D; Nunna V; Bellampalli SS; François-Moutal L; Dumaire N; Salih L; Luo S; Porreca F; Ibrahim M; Rogemond V; Honnorat J; Khanna R; Moutal A
bioRxiv; 2024 May; ():. PubMed ID: 38766071
[TBL] [Abstract][Full Text] [Related]
2. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
3. An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.
Wang S; Hou H; Tang Y; Zhang S; Wang G; Guo Z; Zhu L; Wu J
Neural Regen Res; 2023 Nov; 18(11):2357-2364. PubMed ID: 37282453
[TBL] [Abstract][Full Text] [Related]
4. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent.
Ibrahim Ismail I; K John J; Ibrahim M; Al-Hashel JY
Case Rep Neurol; 2020; 12(1):50-55. PubMed ID: 32110228
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report.
Liu B; Zhou L; Zheng Y; Sun C; Lin J
Brain Sci; 2023 Feb; 13(3):. PubMed ID: 36979184
[TBL] [Abstract][Full Text] [Related]
7. Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
Uysal SP; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Conway DS; Ontaneda D; Morren JA; Kunchok A
Ann Clin Transl Neurol; 2024 Mar; 11(3):710-718. PubMed ID: 38251800
[TBL] [Abstract][Full Text] [Related]
8. Anti-CV2/Collapsin Response Mediator Protein 5 (CRMP5) Paraneoplastic Encephalitis Induced by Small Cell Lung Cancer.
Helgason VÞ; Qureshi PAAA; Bollineni VR; Þórarinsson BL; Arkink EB
Cureus; 2023 Jan; 15(1):e34323. PubMed ID: 36865958
[TBL] [Abstract][Full Text] [Related]
9. Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.
Yan J; Chen Z; Liang Y; Yang H; Cao L; Zhou Y; Zhao Y; Zhang Y
J Int Med Res; 2020 Dec; 48(12):300060520974466. PubMed ID: 33305627
[TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathies associated with antibodies directed to intracellular neural antigens.
Antoine JC
Rev Neurol (Paris); 2014 Oct; 170(10):570-6. PubMed ID: 25194475
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report.
Aydin D; Somnier F; Lassen LH
Case Rep Neurol; 2016; 8(1):16-9. PubMed ID: 26889151
[TBL] [Abstract][Full Text] [Related]
12. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
[TBL] [Abstract][Full Text] [Related]
13. Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamide.
Chu L; Clift F
Mult Scler Relat Disord; 2020 May; 40():101964. PubMed ID: 32044694
[TBL] [Abstract][Full Text] [Related]
14. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
Sato C; Kano T; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.
Juárez-Vignon Whaley JJ; Carrera-Muiños A; Hernandez-Gutierrez KG; Rodriguez-Cid JR; Otero-Cerdeira ME; Garcia-Montes V
Case Rep Oncol; 2021; 14(3):1799-1805. PubMed ID: 35111012
[TBL] [Abstract][Full Text] [Related]
16. Pitfalls in the detection of CV2 (CRMP5) antibodies.
Sabater L; Saiz A; Dalmau J; Graus F
J Neuroimmunol; 2016 Jan; 290():80-3. PubMed ID: 26711575
[TBL] [Abstract][Full Text] [Related]
17. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
18. Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine.
Ha J; Na BS; Ahn JH; Kim M; Kim JW; Lee JH; Cho JW; Kim JS; Youn J
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31656691
[TBL] [Abstract][Full Text] [Related]
19. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
Dubey D; Lennon VA; Gadoth A; Pittock SJ; Flanagan EP; Schmeling JE; McKeon A; Klein CJ
Neurology; 2018 Jan; 90(2):e103-e110. PubMed ID: 29222126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
